2024–2025 · research · Catalyst Grant: Sexually Transmitted and Blood-Borne Infections (STBBI) Research in Canada: Beyond HIV/AIDS and Hepatitis C - Chlamydia

Enhancing effective local immune responses to repeated Chlamydia infection

Jean Marshall · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 99.5kReproductive tract infections research

2024–2029 · research · Project Grant

Type II alveolar epithelial cell regulation of alveolar macrophage development, metabolism and immune function by a novel NKR-P1:Clr interaction.

Andrew Makrigiannis · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 738.2k

2024 · fellowship · Travel Awards - Institute Community Support

Social and structural determinants of injection drug use-associated bacterial and fungal infections: A qualitative systematic review and thematic synthesis

Thomas Brothers · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 3 000HIV, Drug Use, Sexual Risk

2024–2028 · research · Project Grant

Changing primary care capacity in Canada (4C): A cross-provincial mixed methods study to inform workforce planning

Miriam (Ruth) Lavergne · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 1MPrimary Care and Health Outcomes

2024–2025 · planning · Planning and Dissemination Grant - Institute Community Support

Planning Grant - Creation of a pan-Canadian working group to develop and answer complex oral health questions using omics approaches and large public health data sets from the CHMS cycle 7.

Leigha Rock · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 20k

2024–2029 · research · Project Grant

Determining how PRP4K insufficiency impacts cancer signaling and therapy responses

Graham Dellaire · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 1.2M

2024–2027 · research · Operating Grant: Clinical Trials Projects - Indirect Costs

Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR

Scott Halperin · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 1.1MInfluenza Virus Research Studies

2024–2027 · fellowship · Doctoral Research Award: Canada Graduate Scholarships

Sustaining Transitions in Care Innovations for Youth using Knowledge Translation Interventions

Megan Churchill · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 120kAdolescent and Pediatric Healthcare

2024–2029 · fellowship · Canada Research Chairs - CIHR Funded - Tier 2

Multigenerational Trauma and Resilience in First Nations Peoples

Amy Bombay · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 600kIndigenous Health, Education, and Rights

2024–2025 · planning · Planning and Dissemination Grant - Institute Community Support

Planning and co-designing a school-based longitudinal study on student mental health in China

Jianli Wang · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 20k

2024–2025 · grant · Catal. Gr.:Transf. Public Health: Supp. res. on priorities outlined in the CPHO Report - Centre for Res. on Pandemic Prepar. and Health Emerg.

From Wisdom to Wellness: Initiating an Innovative Health Promotion Strategy of Older-Adult-Led Wellness Check Network (OALWCN) in Emergency Preparedness and Response

Haorui Wu · Dalhousie University · funded by Canadian Institutes of Health Research

CAD 125k

2024 · infrastructure · John R. Evans Leaders Fund

Metabolic regulation of KNDy neuron development.

Alejandro Lomniczi · Dalhousie University · funded by Canada Foundation for Innovation

CAD 124.4k